Effects of a collagen matrix containing prostaglandin E1 on wound contraction

Journal of Dermatological Science

Volumn 25, Issue 2, 2001, Pages 106-115

  Ono, Ichiro ^a   Zhou, Li Jun ^a   Tateshita, Tohru ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Collagen gel contraction; Dermal substitute; Prostaglandin E1; Rabbit model; Wound contraction; Wound healing

Indexed keywords

COLLAGEN; PROSTAGLANDIN E1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT; WOUND; WOUND CONTRACTION; WOUND HEALING;

ALPROSTADIL; ANIMALS; COLLAGEN; CONTRACTURE; DRUG COMBINATIONS; FIBROBLASTS; GELS; RABBITS; SKIN; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0035167385     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(00)00126-2     Document Type: Article

References (36)

1. Chemoattractants and growth factors
2. Dermal wound repair: role of collagen matrix implants and synthetic polymer dressings
3. Growth factors and wound healing: biochemical properties
4. Growth factors and wound healing: part II. Role in normal and chronic wound healing
5. Collagen as a biomaterial
6. A new type of biomaterial for artificial skin: dehydrothermally cross-linked composites of fibrillar and denatured collagens
7. Evaluation of an artificial dermis full-thickness skin defect model in the rat
8. Histological evaluation of skin reconstruction using artificial dermis
9. Histologic study of artificial skin used in the treatment of full-thickness thermal injury
10. Heterologous collagen matrix sponge: histologic and clinical response to its implantation in third-degree burn injuries
11. Effects of cytokines in burn blister fluids on fibroblast proliferation and their inhibition with the use of neutralizing antibodies
12. Fibroblast and epidermal cell-type I collagen interactions; cell culture and human studies
13. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
14. 1 on human keratinocytes and dermal fibroblasts, A possible mechanism for the healing of skin ulcers
15. 1 on cultured dermal fibroblasts from normal and hypertrophic scars
16. 1 in the treatment of burned ulcers
17. Effects of a collagen matrix containing basic fibroblast growth factor on wound contraction
18. Effect of a collagen matrix containing epidermal growth factor on wound contraction
19. Determination of endogenous cytokines in chronic wounds
20. Safety and effect of topical recombinant human interleukin-1 β in the management of pressure sores
21. 1, and basic fibroblast growth factor in dermal wound healing
22. 1 reduces expansion of open wounds in the fetal rabbit
23. Interleukin-1 and transforming growth factor-alpha: synergistic stimulation of metalloproteinases, PGE2, and proliferation in human fibroblasts
24. Eicosinoid, cytokines, and free radicals
25. 2 production and cyclooxygenase 2 activity in fibroblasts
26. 2 on wound healing in rats
27. Failure of topical prostaglandin inhibitors to improve wound healing following deep partial-thickness burns
28. Characterization of wound cytokines in the sponge matrix model
29. Studies on cytokines related to wound healing in donor site wound fluid
30. Studies on cytokines related to wound healing in burn blister fluid
31. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds
32. The future of recombinant growth factors in wound healing
33. Manipulation of the wound-healing process with basic fibroblast growth factor
34. Biological analysis of acute and chronic wound environments
35. Preclinical wound-healing studies with recombinant human basic fibroblast growth factor
36. Vascularized collagen-glycosamineoglycan matrix provides a dermal substitute and improves take of cultured epithelial autografts